Every new New York filing, every dayUnicycive Therapeutics is a public biotech company developing therapies for chronic kidney disease, including a phosphate binder for hyperphosphatemia. The website provides detailed information about their pipeline, investors, and corporate communication.
Filed March 31, 2025 · Manhattan, NY
Your competitors in Manhattan are getting unlimited new business leads.

Every new New York filing, every day
See how it worksUnicycive Therapeutics is a biotechnology business (Corp) registered on March 31, 2025 with the New York Division of Corporations. The business is located in Manhattan, New York 10005.
New verified leads every morning, and an AI-built email campaign ready to go. We build it, you hit send.
Build My Campaign Free ›We matched this business to its website and pulled the domain's registration (WHOIS) record. Domain age is one of the strongest signals that a filing is a truly new business and not a re-filing or paperwork change.
Filing timeline will be available soon.
Unicycive Therapeutics was registered as Corp on March 31, 2025 in New York.
Unicycive Therapeutics is based in Manhattan, NY, 10005.
Unicycive Therapeutics is classified as a biotechnology business (kidney disease therapeutics).
No EIN was found on file for Unicycive Therapeutics at the time of registration.
Based on the business category, these service providers typically target this type of business.